Financing channel feed – Endpoints News

Financing channel feed

Investors pour $370M+ into Ken Song's autoimmune biotech after his RayzeBio success

10 months ago

MBX seeks $114M IPO to compete with Ascendis and get a long-acting GLP-1/GIP prodrug into the clinic

10 months ago

Eli Lilly invests in Superluminal's $120M Series A round as AI-focused startups eye the clinic

10 months ago

Bicara, Zenas outline plans for $180M IPOs amid restored optimism for biotech debuts

10 months ago

Exclusive: Lilly-backed OrsoBio raises $67M for slate of obesity drugs as combinations take root

10 months ago

MDLive veterans nab $7.5M Series A for virtual specialty care startup

10 months ago

Exclusive: ZipBio launches using generative AI to make compact proteins

10 months ago

Transplant biotech eGenesis snags $191M after first use of gene-edited pig kidney

10 months ago

Cell therapy startup ArsenalBio raises $325M as it runs early solid tumor trials

10 months ago

BioAge files for IPO, riding momentum for weight loss drugs

10 months ago

Exclusive: Noetik raises $40M Series A to advance AI ambitions in cancer — with an unlikely lead investor

10 months ago

Duality Biologics, an ADC partner of BeiGene and BioNTech, files for Hong Kong IPO

10 months ago

Former Regenxbio leaders take rare disease gene therapies to startup with $15M

10 months ago

Elektrofi, a startup that helps drugmakers formulate biologics for easier delivery, is raising a $112M Series C

10 months ago

RA Capital and Forbion set up new autoimmune biotech with bispecific from Korean startup

10 months ago

Major Galapagos investor says it will push board on company's 'performance' and 'strategic opportunities'

10 months ago

Peptide biotech MBX submits IPO plans, making a trio of post-Labor Day Nasdaq hopefuls

10 months ago

Oncology biotech Bicara unveils IPO pitch same day as Zenas

10 months ago

Autoimmune biotech Zenas files for IPO amid summer lull for public debuts

10 months ago

Illumina Ventures sets out for $300M third fund

10 months ago

Versant and Novartis build 'Chinook 2.0' for RNA therapies in kidney diseases

10 months ago

BridgeBio forms another offshoot with $300M in commitments

10 months ago

After Pfizer layoffs, Array chemists regather at next-gen obesity biotech Ambrosia Biosciences

10 months ago

TCGX and JPM help Pathalys raise $105M to go up against Amgen in subset of kidney disease

10 months ago

First page Previous page 10 11 121314 15 16 Next page Last page